MITOTAX 100MG INJECTION

About

Mitotax 100mg Injection contains Paclitaxel, a highly effective antineoplastic agent classified within the taxane family. Its primary mechanism of action involves disrupting the normal dynamics of microtubule formation and breakdown, which are essential for cell division. Paclitaxel promotes the assembly of microtubules from tubulin dimers and, crucially, stabilizes them, preventing their depolymerization. This stabilization leads to the accumulation of non-functional microtubules within the cell, effectively arresting the cell cycle in the M-phase and ultimately inducing apoptosis in rapidly proliferating cancer cells. This cytotoxic effect makes Mitotax a cornerstone in the treatment of various solid tumors. It is widely indicated for advanced ovarian cancer, metastatic breast cancer, non-small cell lung cancer (NSCLC), and AIDS-related Kaposi's sarcoma, often administered as part of a combination chemotherapy regimen to maximize therapeutic efficacy and improve patient outcomes.

Uses

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer (NSCLC)
• AIDS-related Kaposi's sarcoma

Directions For Use

Administered intravenously by a healthcare professional, typically over 3 or 24 hours. Premedication is required to prevent hypersensitivity reactions.

Benefits

• Broad-spectrum anticancer activity.
• Effective in various solid tumors.
• Can be used as monotherapy or in combination.
• Well-established efficacy in metastatic settings.
• Induces tumor regression.
• Improves survival rates in certain cancers.

Side Effects

• Myelosuppression (neutropenia, anemia, thrombocytopenia)
• Peripheral neuropathy
• Hypersensitivity reactions
• Nausea and vomiting
• Alopecia
• Myalgia/arthralgia
• Diarrhea
• Mucositis
• Bradycardia
• Hypotension
• Elevated liver enzymes
• Fatigue

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may exacerbate gastrointestinal side effects or interact with the drug's metabolism.
• Pregnancy - Contraindicated in pregnancy due to significant fetal harm; use effective contraception during and after treatment.
• Breastfeeding - Advise against breastfeeding due to the potential for serious adverse reactions in breastfed infants.
• Liver - Use with caution in patients with hepatic impairment; dose reduction is often necessary.
• Kidney - Use with caution in patients with severe renal impairment; monitor kidney function closely.
• Lung - Monitor for new or worsening pulmonary symptoms, including interstitial pneumonitis or fibrosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.